![](https://cameronpartners.co.nz/wp-content/uploads/2024/08/orbitremit-1-scaled.jpg)
Sale of Optimal Clinical Trials
to New Zealand Clinical Research
![](https://cameronpartners.co.nz/wp-content/uploads/2024/05/Optimal-Clinical-Trials.jpg)
- Cameron Partners advised Optimal Clinical Trials on its sale to New Zealand Clinical Research
- Optimal Clinical Trials is one of the largest providers of late phase (phase 1b to 3) outpatient clinical research in New Zealand
- New Zealand Clinical Research is New Zealand’s largest clinical trials provider, formed in 2020 by the merger of Auckland Clinical Studies and Christchurch Clinical Studies Trust
- This transaction was a Mid-Market M&A Transaction of the Year finalist at the INFINZ industry awards held in May 2024